Indian or MNC pharma companies? There are reasons to look at both: 5 pharma stocks with upside potential of up to 38%

Around two decades ago, as Indian pharma firms first began to move into the US market, they faced many challenges, the biggest of which was to take the regulator for granted. And the fact is that they still do face challenges; but these are easily handled today as they have grown much bigger and are much more stable in overall terms.